These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 7752647)
1. Bradycardic agent UL-FS 49 attenuates ischemic regional myocardial dysfunction and reduces infarct size in swine: comparison with the beta-blocker atenolol. Schulz R; Rose J; Skyschally A; Heusch G J Cardiovasc Pharmacol; 1995 Feb; 25(2):216-28. PubMed ID: 7752647 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. Indolfi C; Guth BD; Miura T; Miyazaki S; Schulz R; Ross J Circulation; 1989 Oct; 80(4):983-93. PubMed ID: 2791256 [TBL] [Abstract][Full Text] [Related]
3. Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent. O'Brien P; Drage D; Saeian K; Brooks HL; Warltier DC Am Heart J; 1992 Mar; 123(3):566-74. PubMed ID: 1539507 [TBL] [Abstract][Full Text] [Related]
4. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Heusch G; Skyschally A; Gres P; van Caster P; Schilawa D; Schulz R Eur Heart J; 2008 Sep; 29(18):2265-75. PubMed ID: 18621770 [TBL] [Abstract][Full Text] [Related]
5. Role of heart rate reduction in the treatment of exercise-induced myocardial ischaemia. Guth BD; Heusch G; Seitelberger R; Matsuzaki M; Ross J Eur Heart J; 1987 Dec; 8 Suppl L():61-8. PubMed ID: 3451884 [TBL] [Abstract][Full Text] [Related]
6. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Schulz R; Rose J; Martin C; Brodde OE; Heusch G Circulation; 1993 Aug; 88(2):684-95. PubMed ID: 8393390 [TBL] [Abstract][Full Text] [Related]
7. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function. Dämmgen JW; Lamping KA; Gross GJ J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of benefit in the ischemic myocardium due to heart rate reduction. Guth BD; Indolfi C; Heusch G; Seitelberger R; Ross J Basic Res Cardiol; 1990; 85 Suppl 1():157-66. PubMed ID: 1965395 [TBL] [Abstract][Full Text] [Related]
9. Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Guth BD; Heusch G; Seitelberger R; Ross J Circulation; 1987 Mar; 75(3):661-9. PubMed ID: 3815774 [TBL] [Abstract][Full Text] [Related]
10. Effect of a bradycardic agent on the isolated blood-perfused canine heart. Schipke JD; Harasawa Y; Sugiura S; Alexander J; Burkhoff D Cardiovasc Drugs Ther; 1991 Apr; 5(2):481-8. PubMed ID: 1854656 [TBL] [Abstract][Full Text] [Related]
11. Coronary artery thrombosis and thrombolysis in baboons: the effect of atenolol treatment on myocardial infarct size. Herijgers P; Flameng W Eur Heart J; 1991 Oct; 12(10):1084-8. PubMed ID: 1782934 [TBL] [Abstract][Full Text] [Related]
12. Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs. Matsuzaki M; Guth B; Tajimi T; Kemper WS; Ross J Circulation; 1985 Jul; 72(1):233-43. PubMed ID: 4006133 [TBL] [Abstract][Full Text] [Related]
13. Effect of zatebradine on contractility, relaxation and coronary blood flow. Breall JA; Watanabe J; Grossman W J Am Coll Cardiol; 1993 Feb; 21(2):471-7. PubMed ID: 8426013 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function. Gout B; Jean J; Bril A J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735 [TBL] [Abstract][Full Text] [Related]
15. Effects of the bradycardic agent UL-FS 49 on exercise-induced regional contractile dysfunction in dogs. Raberger G; Krumpl G; Schneider W Int J Cardiol; 1987 Mar; 14(3):343-54. PubMed ID: 3557712 [TBL] [Abstract][Full Text] [Related]
16. The selective bradycardic effects of zatebradine (UL-FS 49) do not adversely affect left ventricular function in conscious pigs with chronic coronary artery occlusion. van Woerkens LJ; van der Giessen WJ; Verdouw PD Cardiovasc Drugs Ther; 1992 Feb; 6(1):59-65. PubMed ID: 1576097 [TBL] [Abstract][Full Text] [Related]
17. Atenolol depresses post-ischaemic recovery in the isolated rat heart. Allibardi S; Merati G; Chierchia S; Samaja M Pharmacol Res; 1999 Jun; 39(6):431-5. PubMed ID: 10373241 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the haemodynamic effects of the selective bradycardic agent UL-FS 49, with those of propranolol during treadmill exercise in dogs. Krumpl G; Winkler M; Schneider W; Raberger G Br J Pharmacol; 1988 May; 94(1):55-64. PubMed ID: 3401644 [TBL] [Abstract][Full Text] [Related]
19. Effects of R56865, an Na(+)- and Ca(2+)-overload inhibitor, on myocardial injury in ischemic, reperfused porcine hearts. Klein HH; Pich S; Lindert-Heimberg S; Maisch B; Nebendahl K J Cardiovasc Pharmacol; 1995 Jan; 25(1):163-7. PubMed ID: 7723346 [TBL] [Abstract][Full Text] [Related]
20. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. Van de Werf F; Janssens L; Brzostek T; Mortelmans L; Wackers FJ; Willems GM; Heidbüchel H; Lesaffre E; Scheys I; Collen D J Am Coll Cardiol; 1993 Aug; 22(2):407-16. PubMed ID: 8335810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]